19 results
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Osteomyelitis - IDSA ... #Parenteral #IV ... #Antibiotics #Osteomyelitis ... #pharmacology #idsa
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... for Preventing ... PO (or 400 mg IV ... PO (or 400 mg IV ... Enteric #Bacterial #IDSA
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... for Preventing ... Infections in HIV-AIDS Preventing ... to 5 mg/kg/day IV ... Penicilliosis #IDSA
IDSA - Antimicrobial Regimens for Acute Bacterial Rhinosinusitis in Children
Initial empirical therapy
 • Amoxicillin-clavulanate (45 mg/kg/day
IDSA - Antimicrobial ... bid) Risk for antibiotic ... –400 mg/kg/day IV ... Antimicrobial #Antibiotics ... Rhinosinusitis #IDSA
IDSA Algorithm for the Management of Purulent skin and soft tissue infections (SSTIs). 
Mild infection: for
IDSA Algorithm for ... drainage plus oral antibiotics ... erysipelas with no focus ... have failed oral antibiotic ... infections #cellulitis #idsa
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... amphotericin B 2–4 mg/kg IV ... amphotericin B 2–4 mg/kg IV ... stibogluconate) 20 mg/kg IV ... Leishmaniasis #Prevention
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 400 mg) PO or IV ... candida #mucosal #IDSA ... #Prevention #Treatment
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... 800 mg) PO (or IV ... 800 mg) PO (or IV ... IsosporaBelli #IDSA ... #Prevention #Treatment
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... for Preventing ... ) in HIV-AIDS Preventing ... valganciclovir or IV ... KaposiSarcoma #Castlemans #IDSA
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
IDSA Recommendations ... for Preventing ... 0.7–1.0 mg/kg IV ... #Cryptococcus #IDSA ... #Prevention #Treatment